{"title":"低剂量甲巯咪唑治疗并发关节炎1例。","authors":"M. Khaledi, A. Aminorroaya, H. Rezvanian","doi":"10.22034/IJPS.2018.37546","DOIUrl":null,"url":null,"abstract":"Here in this paper, we report a 31-year-old case admitted with symptoms of hyperthyroidism that was then diagnosed with Grave's disease (GD) and underwent treatments with a low dosage of methimazole (10 mg/day). 20 days after treatments initiations, she developed antithyroid arthritis syndrome. This patient experienced arthritis and arthralgia in at least 4 joints. And all autoimmune and microbiologic evaluations were negative. She was then completely recovered without any sequelae within 4 days after drug withdrawal. Arthritis as an adverse effect of methimazole is a major and life-threatening adverse effect which requires immediate drug discontinuation and hospitalization. Contrary to what has been thought, we declare that this adverse effect might not be dose dependent as our case developed arthritis following methimazole therapy with a very low dosage (10 mg/day). The aim of the current case report is to help other physicians in order to diagnose and treat possible cases of antithyroid arthritis syndrome.","PeriodicalId":14582,"journal":{"name":"Iranian Journal of Pharmaceutical Sciences","volume":"14 1","pages":"55-62"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Arthritis Associated With Low Dose Methimazole Therapy: A Case Report.\",\"authors\":\"M. Khaledi, A. Aminorroaya, H. Rezvanian\",\"doi\":\"10.22034/IJPS.2018.37546\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Here in this paper, we report a 31-year-old case admitted with symptoms of hyperthyroidism that was then diagnosed with Grave's disease (GD) and underwent treatments with a low dosage of methimazole (10 mg/day). 20 days after treatments initiations, she developed antithyroid arthritis syndrome. This patient experienced arthritis and arthralgia in at least 4 joints. And all autoimmune and microbiologic evaluations were negative. She was then completely recovered without any sequelae within 4 days after drug withdrawal. Arthritis as an adverse effect of methimazole is a major and life-threatening adverse effect which requires immediate drug discontinuation and hospitalization. Contrary to what has been thought, we declare that this adverse effect might not be dose dependent as our case developed arthritis following methimazole therapy with a very low dosage (10 mg/day). The aim of the current case report is to help other physicians in order to diagnose and treat possible cases of antithyroid arthritis syndrome.\",\"PeriodicalId\":14582,\"journal\":{\"name\":\"Iranian Journal of Pharmaceutical Sciences\",\"volume\":\"14 1\",\"pages\":\"55-62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iranian Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22034/IJPS.2018.37546\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22034/IJPS.2018.37546","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Arthritis Associated With Low Dose Methimazole Therapy: A Case Report.
Here in this paper, we report a 31-year-old case admitted with symptoms of hyperthyroidism that was then diagnosed with Grave's disease (GD) and underwent treatments with a low dosage of methimazole (10 mg/day). 20 days after treatments initiations, she developed antithyroid arthritis syndrome. This patient experienced arthritis and arthralgia in at least 4 joints. And all autoimmune and microbiologic evaluations were negative. She was then completely recovered without any sequelae within 4 days after drug withdrawal. Arthritis as an adverse effect of methimazole is a major and life-threatening adverse effect which requires immediate drug discontinuation and hospitalization. Contrary to what has been thought, we declare that this adverse effect might not be dose dependent as our case developed arthritis following methimazole therapy with a very low dosage (10 mg/day). The aim of the current case report is to help other physicians in order to diagnose and treat possible cases of antithyroid arthritis syndrome.
期刊介绍:
Iranian Journal of Pharmaceutical Sciences (IJPS) is an open access, internationally peer-reviewed journal that seeks to publish research articles in different pharmaceutical sciences subdivisions: pharmacology and toxicology, nanotechnology, pharmaceutics, natural products, biotechnology, pharmaceutical chemistry, clinical pharmacy and other pharmacy related topics. Each issue of the journal contents 16 outstanding research articles in area of pharmaceutical sciences plus an editorial written by the IJPS editors on one of the most up to date advances topics in pharmacy. All articles published by IJPS would be permanently accessible online freely without any subscription charges. Authors of the published articles have granted the right to use and disseminate their article to third parties.